We dived deep into the complexities of diffuse large B-cell lymphoma (DLBCL), one of the most aggressive yet potentially curable lymphomas. Drs. Rahul & Rohit Gosain are joined by Dr. John Leonard
In a cohort of adults and adolescents marstacimab produced bleed control superior to that from on-demand bypassing agent.
Ken Culver, MD, of ALK Positive patient advocacy organization, discusses ASCO 2025 data and the importance of moving research for ALK+ NSCLC forward.
Before the development of the ensemble machine learning model, the researchers used “correlation analysis and recursive feature elimination” for feature screening.
Scar tissue in the heart was associated with abnormal heart rhythms among healthy, long-time male endurance athletes age 50 or older, potentially increasing their risk…
9% of patients with multiple myeloma achieve 15-year progression-free survival; Kaplan-Meier curves for PFS (A) and OS (B).
@DNIGabbard: 🧵 Americans will finally learn the truth about how in 2016, intelligence was politicized and weaponized by the most powerful people in the Obama…
In light of reports from the White House that President Donald J. Trump has been diagnosed with Chronic Venous Insufficiency (CVI), the American Heart Association…
Sign up for Blood Cancers Today eNewsletters to join an extensive community of hematologic oncology professionals and get the latest news and insights from the…
AbstractBackgroundCoronary microvascular dysfunction appears to play a major role in the pathogenesis of Takotsubo syndrome (TTS). However, the prognostic value of microvascular function measured i…
